MARKET

ARMP

ARMP

Armata Pharmaceuticals Inc
AMEX

Real-time Quotes | Nasdaq Last Sale

4.260
+0.160
+3.90%
Closed 16:00 11/21 EST
OPEN
4.300
PREV CLOSE
4.100
HIGH
4.400
LOW
4.233
VOLUME
4.48K
TURNOVER
--
52 WEEK HIGH
6.23
52 WEEK LOW
2.155
MARKET CAP
42.32M
P/E (TTM)
-1.0990
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ARMP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ARMP News

  • Armata Pharmaceuticals Q3 EPS $(0.73) Down From $(0.6) YoY
  • Benzinga.11/12 21:21
  • Armata Pharmaceuticals Announces Third Quarter Results and Provides Corporate and Clinical Update
  • PR Newswire.11/12 21:05
  • We're Keeping An Eye On Armata Pharmaceuticals's (NYSEMKT:ARMP) Cash Burn Rate
  • Simply Wall St..10/31 15:52
  • Armata Pharmaceuticals Issues Letter to Shareholders
  • PR Newswire.10/31 11:05

More

Industry

Biotechnology & Medical Research
-0.12%
Pharmaceuticals & Medical Research
+0.43%

Hot Stocks

Name
Price
%Change

About ARMP

Armata Pharmaceuticals, Inc., formerly AmpliPhi Biosciences Corporation, is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products. The Company is engaged in developing these phage product candidates using a discovery and development platform, which is designed for identification, characterization and manufacturing of multiple phage therapies. Each product candidate combines several chosen phages, which target a specific disease-causing bacterial pathogen, such as staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and clostridium difficile (C. difficile). Its product candidates are AB-SA01 and AB-PA01.
More

Webull offers Armata Pharmaceuticals Inc (ARMP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.